🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Steven D. Forsythe

Forest Institute

ORCID: 0000-0003-4099-6642

Also affiliated with National Institutes of Health, University of Alabama at Birmingham, National Cancer Institute, Wake Forest University

EngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

(2023)10.1158/1078-0432.c.6530438
Top 100%
0DataRank
Top 100%0 citations

Richard A. Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph B. D’Agostino +6 more

Papers

Driven by 15 papers — median percentile 0. Top paper: “Bioengineered tumor organoids”.

Bioengineered tumor organoids

Current Opinion in Biomedical Engineering(2020)10.1016/j.cobme.2020.03.005
N/A
0.449DataRank · unranked
19 citations

Andrea Mazzocchi, Ethan Shelkey, Steven D. Forsythe, Mahesh Devarsetty, Shay Söker +1 more

The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions

Cancers(2025)10.3390/cancers17193275
N/A
0.104DataRank · unranked
1 citations

Richard A. Erali, Steven D. Forsythe, Ashok Pullikuth, Rui Zheng-Pywell, Kathleen A. Cummins +6 more

Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0982
N/A
0DataRank · unranked
73 citations

Richard A. Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph B. D’Agostino +6 more

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

Annals of Surgical Oncology(2022)10.1245/s10434-022-12086-y
N/A
0DataRank · unranked
59 citations

Hemamylammal Sivakumar, Richard A. Erali, Nadeem Wajih, Wencheng Li, Perry Shen +5 more

Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research

Scientific Reports(2022)10.1038/s41598-022-17921-6
N/A
0DataRank · unranked
22 citations

Richard A. Erali, Preston Laney, Hemamylammal Sivakumar, Wencheng Li, Aleksander Skardal +3 more

Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature

Journal of Gastrointestinal Cancer(2022)10.1007/s12029-022-00891-3
N/A
0DataRank · unranked
12 citations

Steven D. Forsythe, Daniel J. Gironda, Cecilia R. Schaaf, Nadeem Wajih, Shay Söker +2 more

Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput

Micromachines(2020)10.3390/mi11020208
N/A
0DataRank · unranked
163 citations

Casey Clark, Hemamylammal Sivakumar, KyungMin Yoo, Julio Aleman, Shiny Amala Priya Rajan +8 more

Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform

Scientific Reports(2023)10.1038/s41598-023-38545-4
N/A
0DataRank · unranked
8 citations

Richard A. Erali, Nicholas Edenhoffer, William Q. Meeker, Nadeem Wajih, Cecilia R. Schaaf +7 more

Data from Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

(2023)10.1158/1078-0432.c.6530438
Top 100%
0DataRank
Top 100%0 citations

Richard A. Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph B. D’Agostino +6 more

Data from Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

(2023)10.1158/1078-0432.c.6530438.v1
Top 100%
0DataRank
Top 100%0 citations

Richard A. Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph B. D’Agostino +6 more

Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer

Annals of Surgical Oncology(2024)10.1245/s10434-024-15355-0
N/A
0DataRank · unranked
9 citations

Richard A. Erali, Steven D. Forsythe, Cecilia R. Schaaf, Perry Shen, Edward A. Levine +4 more

Multifaceted modeling of small intestinal neuroendocrine tumors

Endocrine Oncology(2024)10.1530/eo-24-0038
N/A
0DataRank · unranked
1 citations

Steven D. Forsythe, James P. Madigan, Samira M. Sadowski, Stephen G. Andrews

Biofabrication of pheochromocytoma and paraganglioma tumor organoids and assessment of response to systemic therapy

Scientific Reports(2025)10.1038/s41598-025-19806-w
N/A
0DataRank · unranked
1 citations

Steven D. Forsythe, Cecilia R. Schaaf, Nicholas Edenhoffer, William Q. Meeker, Cristian D. Valenzuela +5 more

Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions

Cancers(2023)10.3390/cancers15153756
N/A
0DataRank · unranked
20 citations

Tracey Pu, Stephen G. Andrews, James P. Madigan, Samira M. Sadowski, Steven D. Forsythe

In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids

Tissue Engineering and Regenerative Medicine(2020)10.1007/s13770-020-00258-4
N/A
0DataRank · unranked
41 citations

Steven D. Forsythe, Ethan Shelkey, Shay Söker, Mahesh Devarasetty